Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics? March 23, 2020COVID-19 UpdatesPsoriasisInfectious DiseasesPsoriatic Arthritis
Actor Alan Alda discusses using empathy as an antidote to burnoutJanuary 23, 2020Business of MedicineMental HealthPractice Management
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabeticsNovember 17, 2019Heart FailureDiabetesCardiologyEndocrinologyDrug Therapy
Flu vaccine cuts infection severity in kids and adultsOctober 29, 2019InfluenzaVaccinesInfectious DiseasesPulmonologyPediatricsPreventive Care
Cancer overtakes CVD as cause of death in high-income countriesOctober 26, 2019CAD & AtherosclerosisPreventive CareCardiologyLipid DisordersOncology
Beta-blockers effective, safe for HFrEF with renal dysfunctionSeptember 23, 2019Heart FailureCardiology
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drugSeptember 2, 2019Heart FailureDiabetesCardiologyEndocrinology
Tocilizumab preserves lung function in systemic sclerosisJune 26, 2019Lupus & Connective Tissue DiseasesPulmonologyAutoimmune DiseasesRare Diseases
New risk score predicts cardiac-device infectionMay 15, 2019Arrhythmias & EPHeart FailureInterventional Cardiology & SurgeryCardiology
Consider varying generational needs, preferences in the workplace and with patientsMay 8, 2019Business of MedicinePractice Management
BP control slowed brain damage in elderly hypertensivesMarch 22, 2019HypertensionCardiologyAlzheimer's & CognitionGeriatricsMental Health
AUGUSTUS: Dual surpasses triple therapy when AFib patients have PCI or ACSMarch 19, 2019Arrhythmias & EPThrombosisCardiologyVenous ThromboembolismHematologyDVT & Pulmonary Embolism
ACC, AHA release first cardiovascular disease primary prevention guidelineMarch 17, 2019Preventive CareACC Conference CoverageCardiologyLipid DisordersDiabetesCardiology